Biofilms account for over 80% of device related microbial infections in the body. They are highly resistant to antimicrobial agents and the body's immune system. They contaminate indwelling medical devices such as catheters and joint implants causing tens of thousands of deaths each year. Silver is a well-known antimicrobial. Anti-infective, passive silver coatings have been used on catheters and for burns. These passive coatings, however, cannot deliver a sustained dose to penetrate and kill multiple biofilms. This study proposes an active, iontophoretic, delivery system - Active Antisepsis (AA) - that electronically controls the dose and penetration of silver ions surrounding a treated medical device. This technology has been tested against S.aureus biofilm in a laboratory model. The AA not only killed the biofilm, it penetrated through the initial biofilm layer to kill a second layer of biofilm. In this study, AA will be tested on titanium, a common material used in various indwelling medical devices. Initial objectives include: Coating titanium test coupons with silver. Building a silver ion release controller based on previous prototypes. Testing the AA technology in comprehensive laboratory tests to assess the ability to kill multiple layers of infectious biofilms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI051751-01A2
Application #
6691515
Study Section
Special Emphasis Panel (ZRG1-SSS-K (10))
Program Officer
Perdue, Samuel S
Project Start
2003-09-15
Project End
2004-08-31
Budget Start
2003-09-15
Budget End
2004-08-31
Support Year
1
Fiscal Year
2003
Total Cost
$99,972
Indirect Cost
Name
Rose Biomedical Development Corporation
Department
Type
DUNS #
167293112
City
Denver
State
CO
Country
United States
Zip Code
80220